fb-pixel tracker
News

Caris Life Sciences Announces Presentations at the 2017 San Antonio Breast Cancer Symposium Highlighting Precision Medicine Advances

9,600+ Invasive Breast Cancer Patients Evaluated for Immunotherapy Associated Biomarkers: MSI, TML and PD-L1 Two Datasets Further Validate Utility of the ADAPT Biotargeting System in Breast Cancer IRVING, Texas, Dec. 4, 2017 – Caris Life Sciences®, a leading innovator in molecular science focused on fulfilling the promise of precision medicine, today announced the acceptance of … Continued

Caris Life Sciences to Present at the 29th Annual Piper Jaffray Healthcare Conference

IRVING, Texas, Nov. 20, 2017 – Caris Life Sciences®, a leading innovator in molecular science focused on fulfilling the promise of precision medicine, announced today that David D. Halbert, Chairman and Chief Executive Officer, and David Spetzler, M.S., Ph.D., M.B.A., President and Chief Scientific Officer, will present at the 29th Annual Piper Jaffray Healthcare Conference … Continued

Caris Life Sciences Files Patent Infringement Suit against Foundation Medicine, Inc.

IRVING, Texas, Nov. 7, 2017 – Caris Life Sciences®, a leading innovator in molecular science focused on fulfilling the promise of precision medicine, today announced that the Company has filed a patent infringement suit against Foundation Medicine, Inc. in the United States District Court for the District of Massachusetts Boston Division. Caris is seeking damages … Continued

The Comprehensive Cancer Center Innsbruck Joins Caris Life Sciences’ Precision Oncology Alliance as First International Member

CCCI of the tirol kliniken and the Medical University Innsbruck Joins Elite Group of U.S. Academic and Community-Based Cancer Centers Collaborating to Advance Precision Medicine through Tumor Profiling IRVING, Texas, Oct. 31, 2017 – Caris Life Sciences®, a leading innovator in molecular science focused on fulfilling the promise of precision medicine, today announced that the … Continued

John Wayne Cancer Institute Joins the Precision Oncology Alliance Powered by Caris Life Sciences

John Wayne Cancer Institute Becomes the 18th Organization to Join the Precision Oncology Alliance – Advancing Precision Medicine through Molecular Intelligence IRVING, Texas, Oct. 18, 2017 – Caris Life Sciences®, a leading innovator in molecular science focused on fulfilling the promise of precision medicine, announced today the John Wayne Cancer Institute has joined the company’s … Continued

The St. Jude Crosson Cancer Institute Joins the Precision Oncology Alliance Powered by Caris Life Sciences

St. Jude Medical Center’s Crosson Cancer Institute Joins Elite Group of Academic, Hospital and Community-Based Cancer Centers to Broaden Patient Access and Improve Outcomes with Tumor Profiling IRVING, Texas, October 11, 2017 – Caris Life Sciences®, a leading innovator in molecular science focused on fulfilling the promise of precision medicine, today announced that St. Jude … Continued

Esteemed Researcher and Clinical Oncologist W. Michael Korn, M.D. Joins Caris Life Sciences as Chief Medical Officer

Executive Appointment Further Strengthens the Company’s Position as a Precision Medicine Leader Translating Molecular Insights into Therapeutic Action IRVING, Texas, September 19, 2017 – Caris Life Sciences®, a leading innovator in molecular science focused on fulfilling the promise of precision medicine, today announced the appointment of W. Michael Korn, M.D., as its Chief Medical Officer. … Continued

Caris Life Sciences Announces Presentations at ESMO 2017 Highlighting Ability of its Tumor Molecular Profiling to Develop Therapeutic Strategies

Comprehensive Genomic Profiling Plus of DNA, RNA and Proteins Enables Personalized Therapy Decisions across Immunotherapy, Targeted Therapy and Chemotherapy IRVING, Texas, Sept. 7, 2017 – Caris Life Sciences, a leading innovator in molecular science focused on fulfilling the promise of precision medicine, today announced results from two studies that further validate the benefits of its … Continued

Caris Life Sciences Selected to Perform Genomic Profiling for UC-GENOME Study

IRVING, Texas, Aug. 30, 2017 – The Bladder Cancer Genomics Consortium (BCGC) and Hoosier Cancer Research Network today announced the selection of Caris Life Sciences® to perform genomic profiling for UC-GENOME, a large-scale genomically driven bladder cancer study. The study, also known as HCRN GU15-217, is the first project of the BCGC, a collaborative effort … Continued

Caris Life Sciences’ Molecular Intelligence Platform Identifies Patients with MSI-High (or Mismatch Repair Deficient) Solid Tumors More Likely to Respond to Immunotherapy

Results Published in Science Demonstrate Molecular Profile of Tumor Cells Rather than Tumor Origin Can Drive Therapeutic Strategy IRVING, Texas, June 8, 2017 – Caris Life Sciences®, a leading innovator in molecular science focused on fulfilling the promise of precision medicine, today highlighted an article published in Science containing data on microsatellite instability (MSI) status … Continued

1 2 3 4 5 18

About Our News

Search to find the latest new about Caris Molecular Intelligence®, sign up for news alerts, and be sure to follow us on social media.